Nanalysis Scientific (CVE:NSCI) Reaches New 52-Week Low – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCI) shares hit a new 52-week low during trading on Tuesday . The company traded as low as C$0.11 and last traded at C$0.12, with a volume of 43618 shares changing hands. The stock had previously closed at C$0.13.

Nanalysis Scientific Price Performance

The firm has a market cap of C$13.78 million, a P/E ratio of -1.20 and a beta of -0.75. The company has a current ratio of 1.42, a quick ratio of 1.11 and a debt-to-equity ratio of 71.72. The business has a 50-day moving average of C$0.15 and a two-hundred day moving average of C$0.17.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.